Facing the Omicron variant—how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant is currently the dominant variant globally. This third interim analysis of a living systematic review summarizes evidence on the effectiveness of the coronavirus disease 2019 (COVID-19) vaccine (vaccine effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Külper-Schiek, Wiebe, Piechotta, Vanessa, Pilic, Antonia, Batke, Madeleine, Dreveton, Léa-Sophie, Geurts, Brogan, Koch, Judith, Köppe, Stefan, Treskova, Marina, Vygen-Bonnet, Sabine, Waize, Maria, Wichmann, Ole, Harder, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449804/
https://www.ncbi.nlm.nih.gov/pubmed/36091023
http://dx.doi.org/10.3389/fimmu.2022.940562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449804/
https://www.ncbi.nlm.nih.gov/pubmed/36091023
http://dx.doi.org/10.3389/fimmu.2022.940562

Ejemplares similares